SNV Stock Cash Flow Statements

Synovus Financial Corp Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Synovus Financial Corp Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-03-31	2018-12-31	2018-09-30	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31

operating activities
net income	217,119,000	194,872,000	189,377,000	180,684,000	-14,680,000	124,070,000	69,573,000	96,465,000	173,944,000	202,159,000	205,770,000	203,044,000	178,051,000	171,037,000	200,402,000	186,773,000	186,199,000	187,093,000	150,409,000	91,574,000	93,191,000	38,521,000	120,186,000	105,069,000	109,059,000	38,579,000	45,695,000	45,535,000	29,574,000	724,039,000
adjustments to reconcile net income to net cash from operating activities:
benefit from (reversal of) credit losses	3,245,000	10,921,000	32,867,000	23,434,000	26,404,000	53,980,000	45,472,000	72,572,000	38,881,000	32,154,000	34,884,000	25,581,000	12,688,000	11,400,000
depreciation, amortization, and accretion	13,530,000	11,543,000	12,860,000	13,338,000	16,356,000	17,854,000	29,904,000	21,700,000	21,766,000	20,088,000	15,820,000	16,361,000	9,882,000	27,109,000	33,922,000	39,974,000	31,696,000	52,395,000	28,722,000	27,464,000	26,272,000	23,649,000	7,000,000	13,456,000	13,055,000	12,797,000	13,993,000	14,898,000	17,622,000	17,461,000
deferred income tax expense	2,508,000	6,787,000	4,355,000	6,058,000	6,512,000	2,446,000	-5,990,000	3,633,000	18,488,000	706,000	22,668,000	-8,573,000	-4,477,000	1,250,000	8,787,000	11,102,000	7,185,000	17,926,000					6,915,000	26,855,000	4,138,000	26,314,000	23,645,000	26,053,000	14,403,000
originations of loans held for sale	-2,011,454,000	-1,544,628,000	-1,639,433,000	-1,911,294,000	-2,160,318,000	-468,414,000	-132,264,000	-156,505,000	-168,753,000	-143,149,000	-290,199,000	-966,772,000	-1,179,391,000	-915,873,000	-825,740,000	-830,552,000	-966,733,000	-1,075,343,000	-1,244,868,000	-414,407,000
proceeds from sales and payments on loans held for sale	1,983,084,000	1,515,593,000		1,931,987,000	2,154,295,000	392,753,000		194,831,000	328,212,000	275,274,000		1,187,092,000	979,931,000	946,187,000		1,039,180,000	1,220,217,000	857,872,000
gain on sales of loans held for sale	-3,278,000	-2,523,000	-1,684,000	-2,841,000	-2,713,000	-2,419,000	-1,919,000	-2,042,000	-3,023,000	-2,716,000	-1,289,000	-3,560,000	-2,630,000	-4,647,000	-5,583,000	-9,428,000	-11,209,000	-16,293,000	-17,114,000	-24,216,000
increase in other assets	324,290,000	-96,746,000	-113,459,000	-41,639,000	-152,550,000	-81,810,000	-40,461,000	-95,011,000	-91,831,000	-63,174,000	-132,994,000	53,487,000	-48,989,000	-58,709,000	-51,285,000	-2,570,000			-14,412,000	1,234,458,000	-1,188,967,000	-442,711,000		-19,192,000	-10,126,000
increase in other liabilities	-354,926,000	-50,058,000	96,364,000	49,060,000	142,435,000	-22,298,000	73,647,000	111,159,000	34,112,000	25,417,000	124,668,000	-114,698,000	78,420,000	-5,433,000	7,067,000	-27,187,000	10,382,000	-11,936,000	47,848,000	-941,863,000	915,395,000	260,486,000		4,512,000	9,398,000				-9,477,000
investment securities (gains) losses			0	0			77,748,000	0	0	-1,030,000									-2,337,000	1,550,000
share-based compensation expense	9,111,000	6,496,000	7,986,000	8,442,000	7,707,000	7,914,000	7,373,000	7,900,000	8,240,000	8,711,000	5,519,000	7,874,000	6,177,000	8,334,000	6,310,000	8,354,000	5,467,000	7,664,000	4,768,000	4,953,000	5,350,000	3,570,000	10,244,000	4,139,000	4,184,000		2,421,000	1,531,000	1,819,000
net gain on sales of other real estate and other assets held for sale	0	-355,000	-626,000	-303,000
net cash from operating activities	183,229,000	51,902,000	260,819,000	256,926,000	279,209,000	24,076,000	266,213,000	302,311,000	359,659,000	354,440,000	580,659,000	399,836,000	29,662,000	181,332,000	-49,326,000	406,816,000	416,296,000	20,230,000	225,392,000	674,630,000	-902,751,000	19,761,000	142,508,000	147,062,000	160,017,000	123,565,000	186,176,000	116,002,000	178,783,000	331,168,000
investing activities
proceeds from maturities and principal collections of investment securities held to maturity	60,939,000	49,571,000	57,474,000	63,472,000
proceeds from maturities and principal collections of investment securities available for sale	145,418,000	125,397,000	136,752,000	127,172,000	154,789,000	196,020,000	223,877,000	264,509,000	244,483,000	205,098,000	248,747,000	498,276,000	584,010,000	642,957,000	772,085,000	662,676,000	763,769,000	852,628,000	723,647,000	637,885,000	588,573,000	341,431,000	197,726,000	145,948,000	162,999,000	126,324,000	192,073,000	176,350,000	216,387,000	284,676,000
proceeds from sales of investment securities available for sale			0	0			1,218,925,000	0	0	82,595,000					341,423,000	0	0	223,977,000	122,302,000	1,249,507,000	2,269,681,000	413,180,000	1,188,239,000	0	0	3,926,000	56,406,000	135,146,000	212,240,000	230,073,000
purchases of investment securities available for sale	-47,148,000	-277,156,000	-385,667,000	-378,879,000	-1,617,952,000	-258,482,000	-1,440,498,000	-269,918,000	-247,005,000	-193,009,000	-250,142,000	-767,708,000	-449,348,000	-820,120,000	-1,430,502,000	-1,970,281,000	-1,351,362,000	-2,125,567,000	-1,260,351,000	-2,290,738,000	-3,134,516,000	-755,558,000	-1,800,346,000	-189,397,000	-143,339,000	-237,200,000	-271,519,000	-416,566,000	-509,037,000	-293,172,000
net proceeds from sales of loans	9,248,000	37,000	12,328,000	16,272,000	6,305,000	2,548,000	8,922,000
net increase in loans	-912,850,000	-56,802,000	475,388,000	-66,812,000	177,957,000	28,830,000	226,089,000	-567,069,000	-410,598,000	-773,103,000	-1,165,836,000	-1,226,931,000	-867,680,000	-726,686,000					1,241,901,000	-955,163,000	-1,682,915,000	-1,065,125,000				-424,856,000				-511,908,000
net (purchases) redemptions of federal home loan bank stock	-85,518,000	-16,878,000	36,812,000	13,063,000	-24,000	-16,626,000	33,273,000	45,250,000	57,374,000	-7,439,000	-18,456,000	-99,375,000	-31,873,000	-13,827,000	0	0						-978,000	-24,239,000	843,000	-20,188,000
net (purchases) redemptions of federal reserve bank stock	202,000	-287,000	-314,000	-224,000	27,000	-12,144,000	10,598,000	-115,000	-8,456,000	-7,108,000	11,114,000	4,573,000	-112,000	-424,000								-454,000		-8,782,000	0
net proceeds from settlement (purchases) of bank-owned life insurance policies				760,000				0	846,000	2,514,000		1,393,000				830,000	2,480,000	3,784,000
net increase in premises, equipment and software	-6,532,000	-8,158,000	-11,768,000	-15,848,000	-10,046,000	-18,490,000	-11,650,000	-7,854,000	-6,184,000	-6,519,000	-8,618,000	-10,227,000	-8,598,000	-2,662,000	-5,958,000	-7,577,000	-8,392,000	-4,027,000
proceeds from sales of other real estate and other assets held for sale	0	2,534,000	1,585,000	747,000
net cash from investing activities	-828,708,000	-181,742,000	326,762,000	-240,277,000	169,430,000	-78,344,000	276,339,000	1,025,644,000	-285,566,000	-692,451,000	-1,161,694,000	-1,722,078,000	-937,645,000	-1,034,065,000	-1,283,033,000	-1,433,542,000	-38,067,000	-1,629,524,000	870,565,000	-51,131,000	-1,868,375,000	-1,304,032,000	-648,375,000	-446,122,000	-469,640,000		352,862,000	-389,253,000	171,403,000	-461,631,000
financing activities
net increase in deposits	-923,192,000	-258,749,000	905,813,000	-17,518,000	-387,335,000	-157,277,000	518,957,000	122,263,000	146,923,000	1,070,206,000	1,177,881,000	-1,319,613,000	381,274,000	-771,032,000	1,738,857,000	516,457,000	-196,989,000	677,380,000	2,025,411,000	470,919,000	4,367,530,000	1,420,659,000	434,677,000	286,555,000	-9,174,000
net increase in federal funds purchased, securities sold under repurchase agreements, and other short-term borrowings
repayments and redemption of long-term debt			-775,000,000	-275,000,000			-783,505,000	-1,316,626,000			-300,000,000	0	0	-400,000,000					-632,026,000	-700,154,000	-824,855,000	-251,904,000		0	100,000,000
proceeds from long-term debt	1,800,000,000	350,000,000	496,791,000	0	1,050,000,000	100,000,000	0	0	2,200,000,000	1,020,912,000
dividends paid to common shareholders	-54,736,000	-53,657,000	-53,958,000	-54,798,000	-55,639,000	-55,733,000	-55,558,000	-55,536,000	-55,502,000	-49,465,000	-49,439,000	-49,416,000	-49,442,000	-47,851,000	-48,099,000	-48,651,000	-49,093,000	-48,834,000	-48,614,000	-48,612,000	-48,592,000	-44,149,000	-28,966,000	-29,204,000	-29,510,000	-9,724,000	-9,722,000	-9,105,000	-7,876,000	-7,865,000
dividends paid to preferred shareholders	-11,395,000	-11,323,000	-11,577,000	-9,721,000	-9,713,000	-9,685,000	-9,746,000	-9,623,000	-8,290,000	-8,291,000	-8,291,000	-8,291,000	-8,290,000	-8,291,000	-8,291,000	-8,291,000	-8,290,000	-8,291,000	-8,291,000	-8,291,000	-13,431,000	-3,150,000	-3,150,000	-3,150,000	-5,709,000		-9,544,000	-12,099,000	-12,098,000	-12,099,000
repurchases of common stock	-21,437,000	-120,849,000		-100,891,000	-91,740,000	-30,015,000						0	-3,316,000	-9,671,000		-74,635,000
issuances, net of taxes paid, under equity compensation plans	-3,000	-14,610,000	2,749,000	3,248,000	589,000	-9,091,000	9,157,000	-740,000	129,000	-6,606,000	431,000	131,000	570,000	-3,955,000	3,333,000	-67,000	1,932,000	6,368,000
net cash from financing activities	791,562,000	-157,914,000	552,794,000	-457,645,000	-577,531,000	26,342,000	-228,757,000	-1,244,475,000	-1,385,342,000	1,725,631,000	691,011,000	1,524,986,000	1,019,540,000	-603,617,000	1,654,792,000	451,470,000	-443,819,000	684,643,000	1,171,597,000	-209,361,000	2,518,517,000	1,921,187,000	628,228,000	430,691,000	229,768,000	-6,031,000	-452,831,000	289,433,000	-552,511,000	291,065,000
increase in cash and cash equivalents including restricted cash	146,083,000	-287,754,000	1,140,375,000	-440,996,000	-128,892,000	-27,926,000	313,795,000	83,480,000	-1,311,249,000	1,387,620,000	109,976,000	202,744,000	111,557,000	-1,456,350,000	322,433,000	-575,256,000	-65,590,000	-924,651,000	2,267,554,000	414,138,000	-252,609,000	636,916,000	122,361,000	131,631,000	-79,855,000
cash, cash equivalents, and restricted cash, at beginning of period	0	2,993,987,000		0	0	2,451,426,000		0	0	1,977,780,000		0	0	3,009,853,000		0	0	4,252,917,000
cash, cash equivalents, and restricted cash at end of period	146,083,000	2,706,233,000		-440,996,000	-128,892,000	2,423,500,000		83,480,000	-1,311,249,000	3,365,400,000		202,744,000	111,557,000	1,553,503,000		-575,256,000	-65,590,000	3,328,266,000
supplemental disclosures:
income taxes paid	31,444,000	30,303,000	13,751,000	4,556,000	163,000	28,798,000	9,671,000	2,094,000	5,831,000	52,157,000	36,124,000	51,466,000	41,597,000	46,493,000	53,492,000	35,440,000	66,777,000	48,505,000	42,575,000	67,996,000	-663,000	920,000	1,050,000		1,721,000
interest paid	319,109,000	327,399,000	336,445,000	400,215,000	345,251,000	385,188,000	332,498,000	302,306,000	271,477,000	206,624,000	130,599,000	59,111,000	25,052,000	27,278,000	24,034,000	30,117,000	32,173,000	46,599,000	51,236,000	73,359,000	85,347,000	109,340,000	95,630,000		41,298,000	35,959,000	29,118,000	28,197,000	28,017,000	-246,706,000
non-cash activities
loans foreclosed and transferred to other real estate	635,000	403,000	0	0	782,000	21,210,000									11,444,000	163,000	81,000	720,000	0	150,000	62,000	1,951,000	1,419,000		3,719,000	12,568,000	21,019,000	22,046,000	29,789,000
investment securities transferred from available for sale to held to maturity			0	0
net increase in federal funds purchased and securities sold under repurchase agreements		-48,726,000	37,673,000	-429,000	-33,760,000	-60,830,000	90,804,000	14,886,000	-112,311,000	49,107,000	-93,622,000	-105,032,000	-155,882,000	236,991,000	1,585,000	67,761,000	-98,872,000	65,737,000	25,577,000	-23,231,000	-87,200,000	147,086,000	47,552,000	46,547,000	-16,435,000				36,980,000
net increase in other short-term borrowings			0	-2,536,000	-249,933,000	248,973,000	1,134,000	901,000	-251,691,000	-350,232,000	-11,148,000	359,514,000	-145,374,000	400,192,000
proceeds from sales of loans held for sale																			1,278,660,000	612,396,000
loss on sales of loans							0
other							-4,497,000	-2,455,000			0	0	0	677,000												1,269,000	-1,092,000	-9,107,000	10,656,000	16,191,000
net cash received (paid) for business combination and divestiture							0
purchases of loans							0	0			0	-152,908,000	-180,232,000	-181,335,000	-129,258,000	-453,322,000	-434,617,000	-606,985,000
net (purchases) proceeds from settlement of bank-owned life insurance policies																			5,723,000	1,250,000	669,000	-249,942,000
repurchase of common stock																			0	0	0	-16,246,000	-320,167,000	-40,268,000	-57,994,000
cash, cash equivalents, and restricted cash at beginning of year
cash, cash equivalents, and restricted cash at end of year
non-cash activities:
settlement of acquired debt							0	0
net cash received in business combination, net of cash paid																							201,100,000
proceeds from sales of loans									82,627,000	1,505,000	6,625,000	16,029,000	7,562,000	39,568,000	5,415,000	19,103,000	65,115,000	21,535,000	133,588,000	1,275,397,000	6,161,000	11,808,000	13,654,000	7,461,000	1,500,000		474,000	34,551,000	40,334,000
loans transferred (from) to other loans held for sale									3,799,000	424,104,000
loans transferred to (from) loans held for sale at fair value
premises and equipment transferred to other assets held for sale											4,796,000	5,995,000	1,660,000	11,712,000		18,861,000						4,681,000			0
proceeds from issuance of long-term debt												2,647,693,000							197,051,000	0	0	1,248,441,000	297,045,000	0	0	155,000,000	150,768,000			200,000,000
securities purchased during the period but settled after period-end																	-4,904,000	53,699,000				113,818,000
loans transferred (from) to other loans held for sale at fair value												-4,469,000	-8,331,000	-1,055,000
net purchases of federal reserve bank stock															-10,000	-256,000			-204,000	0
proceeds from issuance of preferred stock
common stock issued, treasury stock reissued, equity awards/warrants exchanged to acquire fcb																							1,625,688,000
(reversal of) benefit from credit losses																-7,868,000	-24,598,000	-18,575,000
investment securities losses (gains)																-962,000	0	1,990,000
goodwill impairment
net decrease (increase) in loans																310,574,000	923,000,000	5,084,000
net decrease in other short-term borrowings																0	0	-7,717,000
securities sold during the period but settled after period end
dividends declared on common stock during the period but paid after period-end																-552,000	-442,000	49,093,000		2,000	14,000	48,598,000	47,235,000		-299,000
dividends declared on preferred stock during the period but paid after period-end																0	0	5,141,000		0	0	5,141,000
loans transferred to other loans held for sale at fair value																						11,893,000				6,525,000	30,617,000	41,008,000	46,181,000
adjustments to reconcile net income to net cash (used) provided by operating activities:
decrease (increase) in other assets																		17,437,000					21,634,000						14,888,000
net purchases of federal home loan bank stock																		-1,200,000
securities sold during the period but settled after period-end																						169,748,000
benefit from credit losses																			11,066,000	43,383,000	141,851,000	158,722,000
deferred income tax (benefit) expense																			-25,759,000	-5,692,000	-43,763,000	-10,978,000
net redemptions (purchases) of federal home loan bank stock																			32,938,000	25,500,000
proceeds from issuance (redemption) of preferred stock
loans transferred to loans held for sale at fair value																			3,643,000	-887,175,000
dividends declared on common stock during the year but paid after year-end
dividends declared on preferred stock during the year but paid after year-end
loss on early extinguishment of debt																				153,000	0	1,904,000
proceeds from sales of equity securities																				0
proceeds from sales of other real estate and other assets																				7,831,000	1,826,000	8,547,000	6,273,000	4,178,000	1,939,000
net increase in premises and equipment																				-2,600,000	-13,245,000	-6,941,000	-9,209,000	-14,125,000	-12,254,000
net change in other short-term borrowings																				100,000,000	-875,000,000	-578,560,000	203,000,000
stock options and warrants exercised																				32,000	212,000	6,267,000	6,649,000		181,000
taxes paid related to net share settlement of equity awards																				-24,000	-147,000	-7,257,000	-8,412,000	-93,000	-131,000
cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period																				0	0	1,186,918,000	1,143,564,000		0
cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period																				414,138,000	-252,609,000	1,823,834,000	1,265,925,000		-79,855,000
originations of mortgage loans held for sale																						-254,395,000	-120,207,000	-113,542,000	-143,461,000	-92,105,000	-209,495,000	-293,852,000	-246,090,000	-333,661,000
proceeds from sales of mortgage loans held for sale																						259,224,000	104,552,000	116,021,000	162,476,000	107,166,000	271,397,000	308,586,000	313,365,000	368,245,000
gain on sales of mortgage loans held for sale																						-9,497,000	-3,534,000	-2,405,000	-3,688,000		-2,758,000	-4,085,000	-3,946,000
investment securities gains																						-8,734,000	-75,000			-374,000			-45,000
benefit from loan losses																							23,569,000	12,149,000	14,982,000	14,064,000	6,761,000	13,077,000	35,696,000	146,526,000
investment securities losses																									0
net increase in loans excluding loans acquired in business combination																							-423,514,000		-460,297,000
proceeds from settlement (purchases) of bank-owned life insurance policies
redemption of preferred stock
earnout payment
cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of year
cash, cash equivalents, restricted cash, and restricted cash equivalents at end of year
decrease in other liabilities																							-27,776,000			-2,639,000	12,094,000
net redemptions (purchases) of federal reserve bank stock																							1,285,000
purchases of bank-owned life insurance policies, net of settlements																							656,000
loans transferred to/(from) other loans held for sale at fair value																							12,237,000
subtopic 825-10 equity investment securities available for sale transferred to other assets																									0
net cash received in acquisition																										0	0
net increase in loans including purchases of loans
net proceeds from issuance of series d preferred stock
redemption of series c preferred stock
stock options exercised																										255,000	655,000	83,000	51,000
proceeds from settlements of bank-owned life insurance policies																									0
proceeds from issuance of series d preferred stock
decrease in trading account assets																													2,062,000
losses and write-downs on other real estate																										2,794,000	8,400,000
losses and write-downs on other assets held for sale
net increase in interest earning deposits with banks
net increase in federal funds sold and securities purchased under resale agreements																													-9,361,000
net increase in interest bearing funds with federal reserve bank
proceeds from sales of loans and principal repayments on other loans held for sale
proceeds from sales of other real estate																											27,633,000	32,099,000	17,436,000
proceeds from sales of other assets held for sale																											167,000	375,000	543,000
net increase in demand and savings deposits																										166,529,000	135,329,000	215,338,000	-631,934,000	248,430,000
net increase in certificates of deposit																											127,824,000	-122,655,000	136,083,000
repayments on long-term debt
restricted stock activity																										-23,000	-2,060,000	0	-1,481,000
increase in cash and cash equivalents																														160,602,000
cash and cash equivalents at beginning of period																											0	0	614,630,000
cash and cash equivalents at end of period																											86,207,000	16,182,000	412,305,000
decrease in interest receivable																										-2,050,000	3,753,000	2,009,000	2,467,000	2,825,000
decrease in interest payable																										74,000	-327,000			153,000
gain on sale of mortgage loans held for sale
decrease in other assets
increase in accrued salaries and benefits																										-2,060,000				264,000
gain on sale of other loans held for sale
decrease (increase) in fair value of private equity investments																										2,107,000	-284,000	883,000	257,000
gain on other assets held for sale
write downs of other assets held for sale
increase in accrual for visa indemnification																										799,000	0	764,000	37,000
share-based compensation																														2,426,000
net decrease in federal funds sold and securities purchased under resale agreements																										-798,000	8,459,000
net decrease in interest bearing funds with federal reserve bank																										321,907,000	482,142,000
proceeds from sale of loans
proceeds from sale of other real estate																														41,354,000
principal repayments by borrowers on other loans held for sale																										31,000	3,632,000	272,000	62,000
purchases of premises and equipment																										-6,598,000			-6,374,000	-13,080,000
proceeds from disposals of premises and equipment																										-73,000	3,151,000	17,000	4,000	200,000
proceeds from sale of other assets held for sale
net cash (used) provided by investing activities
net decrease in certificates of deposit
principal repayments on long-term debt																										-6,140,000	-150,624,000	-78,498,000	-72,309,000	-126,710,000
transfer of funds to dividend payment agent
dividends paid on series c preferred stock
dividends paid on series a preferred stock
proceeds from issuance of series c preferred stock, net of issuance costs
redemption of series a preferred stock																										0
proceeds from issuance of common stock, net of issuance costs
excess tax benefit from share-based compensation																										6,000
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
supplemental cash flow information
cash paid (received) during the period for:
income tax payments (refunds)																										908,000	232,000	-35,238,000	36,675,000
decrease in net unrealized gains on available for sale securities, net of income taxes																										-11,768,000	3,521,000	-36,440,000	-1,360,000
net change related to cash flow hedges, net of income taxes
net change in post-retirement unfunded health benefit, net of income taxes
mortgage loans held for sale transferred to loans at fair value																										243,000	0			417,000
other loans held for sale transferred to loans at fair value																										0	0	0	1,235,000
other loans held for sale foreclosed and transferred to other real estate at fair value																										0	1,851,000	0	1,395,000	0
premises and equipment transferred to other assets held for sale at fair value																										5,764,000	288,000	166,000	36,000
write down to fair value for other loans held for sale
impairment loss on available for sale securities
accretion of discount for series a preferred stock
settlement of prepaid common stock purchase contracts																										0	0
acquisition:
fair value of non-cash assets acquired																										0	0
fair value of liabilities assumed																										0	0
increase in trading account assets																											5,706,000
losses on sales of other loans held for sale																													165,000
net decrease (increase) in interest earning deposits with banks																											5,954,000
net increase in federal funds purchased, securities sold under repurchase agreements, and other short-term liabilities																											-28,320,000
proceeds from issuance of series c preferred stock
proceeds from issuance of common stock
decrease in cash and cash equivalents																													-202,325,000
cash paid (received) paid during the period for:
decrease (increase) in net unrealized losses on hedging instruments, net of income taxes
accretion of discount on series a preferred stock																											5,145,000	2,720,000	2,678,000
amortization of post-retirement unfunded health benefit, net of income taxes																											-44,000
securities purchased (sold) during the period but settled after period-end
gain on sales of premises and equipment																												-610,000	603,000
decrease in accrued salaries and benefits
investment securities (gains)
losses (gains) on sales of other loans held for sale
(gains) on sales of other assets held for sale
write-downs on other assets held for sale																												0	170,000
net (increase) in loans
purchases of premises and equipment, net of disposals
decrease (increase) in net unrealized gains on hedging instruments, net of income taxes																												67,000	69,000
increase in interest payable																													-2,109,000
(decrease) in accrued salaries and benefits																													-12,090,000
losses on other real estate																													8,783,000	31,245,000
gains on sales of other assets held for sale																													-27,000
net decrease in interest earning deposits with banks																													1,552,000
net decrease (increase) in interest bearing funds with federal reserve bank																													165,878,000
net decrease in loans																													41,739,000
excess tax benefit from share-based payment arrangements																													73,000
(gain) loss on sale of other loans held for sale
gain on sale of merchant services business
gain on curtailment of post-retirement health benefit
net decrease in federal funds sold and securities purchased under repurchase agreements
proceeds from sale of merchant services business
purchase of treasury shares
proceeds from issuance of prepaid common stock purchase contracts
income tax refunds
non-cash investing activities
(decrease) in unrealized gains net of unrealized losses on available for sale securities
decrease in unrealized gains net of unrealized losses on hedging instruments
amortization of post-retirement unfunded health benefit																														-26,000
loans and other loans held for sale foreclosed and transferred to other real estate
gains on sale of mortgage loans held for sale
increase in prepaid and other assets
increase in fair value of private equity investments
losses (gains) on sales of other assets held for sale
write downs on other assets held for sale
loss on curtailment of post-retirement health benefit plan
net decrease (increase) in federal funds sold and securities purchased under resale agreements
proceeds from sales of other loans held for sale
principal payments on other loans held for sale
net (decrease) in certificates of deposit
net (decrease) in federal funds purchased and securities sold under repurchase agreements
cash (received) paid during the period for:
income tax (refunds) payments
decrease in net unrealized gains on investment securities available for sale
decrease in net unrealized gains on hedging instruments
loans foreclosed and transferred to other real estate at fair value
loans transferred to other loans held for sale, at fair value
other loans held for sale transferred to loans
securities purchased (sold) during the period but settled after period end
accretion of discount for preferred stock issued to the u. s. treasury

We provide you with 20 years of cash flow statements for Synovus Financial Corp stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Synovus Financial Corp stock. Explore the full financial landscape of Synovus Financial Corp stock with our expertly curated income statements.

The information provided in this report about Synovus Financial Corp stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.